Second-line Chemotherapy in Older Patients With Metastatic Urothelial Carcinoma: Pooled Analysis of 10 Second-line Studies-Reference-Cited by-同舟云学术

Second-line Chemotherapy in Older Patients With Metastatic Urothelial Carcinoma: Pooled Analysis of 10 Second-line Studies

Published:2017-08 Issue:4 Volume:15 Page:e563-e571
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Salah Samer,Lee Jae-Lyun,Rozzi Antonio,Kitamura Hiroshi,Matsumoto Kazumasa,Vis Daniel J.,Srinivas Sandy,Morales-Barrera Rafael,Carles Joan,Al-Rimawi Dalia,Lee Soonil,Kim Ki Hong,Izumi Kouji,Lewin Jeremy

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference34 articles.

1. Intravenous 3-weekly paclitaxel and metronomic oral cyclophosphamide in patients with advanced urothelial cancer previously treated with gemcitabine and platinum;Park;Cancer Chemother Pharmacol,2015

2. Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group;Kitamura;Cancer Sci,2011

3. Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum;Lee;Invest New Drugs,2012

4. Paclitaxel with cisplatin as salvage treatment for patients with previously treated advanced transitional cell carcinoma of the urothelial tract;Uhm;Neoplasia,2007

5. A phase II study of docetaxel and oxaliplatin for secondline treatment of urothelial carcinoma;Srinivas;Chemotherapy,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study;Clinical and Experimental Medicine;2023-11-02

2. Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis;Journal for ImmunoTherapy of Cancer;2020-10

3. Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder;Clinical and Translational Oncology;2018-09-04

4. Gemcitabine and docetaxel as second-line chemotherapy in elderly patients with metastatic urothelial carcinoma: a retrospective analysis;Cancer Management and Research;2018-09